Mindray(SZ:300760) Xin Lang Cai Jing·2025-10-17 05:37Core Viewpoint - The stock price of Mindray Medical has experienced a decline of 10.10% year-to-date, with a notable drop of 6.49% over the past five trading days, indicating potential concerns regarding the company's performance and market sentiment [1]. Company Overview - Mindray Medical, established on January 25, 1999, and listed on October 16, 2018, is located in Shenzhen, Guangdong Province. The company specializes in the research, manufacturing, marketing, and service of medical devices [1]. - The revenue composition of Mindray Medical includes: 38.37% from in vitro diagnostic products, 32.73% from life information and support products, 19.78% from medical imaging products, 7.25% from electrophysiology and vascular intervention products, and 1.56% from other products [1]. Financial Performance - As of June 30, 2025, Mindray Medical reported a revenue of 16.743 billion yuan, a year-on-year decrease of 18.45%, and a net profit attributable to shareholders of 5.069 billion yuan, down 32.96% compared to the previous period [2]. - Since its A-share listing, Mindray Medical has distributed a total of 33.699 billion yuan in dividends, with 23.388 billion yuan distributed over the last three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Mindray Medical was 91,600, a decrease of 0.68% from the previous period. The average number of circulating shares per person increased by 0.69% to 13,241 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 131 million shares (a decrease of 3.0252 million shares), and E Fund's various ETFs, with mixed changes in holdings [3].